News
Measuring UK Medicines Expenditure in the Context of the 2014-18 PPRS
29 August 2018
OHE Consulting produces a report on Measuring UK Medicines Expenditure in the Context of the 2014-18 PPRS.
Two New Papers on EQ-5D-5L Valuation in Ireland
21 August 2018
OHE’s Koonal Shah and Nancy Devlin are co-authors on two new papers focusing on the valuation of the EQ-5D-5L in Ireland.
The Impact of New Medicines in the NHS: 70 Years of Innovation
14 August 2018
This year marks the 70th birthday of the NHS. Our latest Consulting Report describes the most important new medicines as identified by experts.
Opportunity Costs of New Health Care Technologies: A Research Agenda
8 August 2018
A new OHE Research Paper sets out an agenda for the development of methods to estimate cost-effectiveness thresholds in the NHS.
Presentations from EuHEA 2018
2 August 2018
OHE staff recently attended the European Health Economics Association (EuHEA) 2018 conference. In this blog post, we share a selection of our presentations. Establishing a Reasonable…
New Journal Article: Directly Eliciting Personal Utility Functions
31 July 2018
A new article in the European Journal of Health Economics describes the ‘personal utility functions’ approach to valuing health
Incentives, Competition, and Pharmaceutical Innovation in Europe: The Case of Direct Acting Antivirals for Hepatitis C
26 July 2018
To what extent can R&D incentives, competition and other factors facilitate access to highly valuable and costly pharmaceutical innovations?
Presentations from AES and PROMs Summer 2018
24 July 2018
OHE staff recently attended AES and PROMs Summer 2018 conferences. In this blog post, we share a selection of our presentations.
OHE’s Paula Lorgelly Elected as HESG Joint National Organiser
23 July 2018
Paula Lorgelly and Bruce Hollingsworth (Lancaster University) have taken the role of joint National Organisers for the Health Economists’ Study Group.